Trough, peak ratio and duration of action: implications for hypertensive effect and organ protection
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Elsevier
1995
|
| Schriftenreihe: | American journal of hypertension
8,10,2 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zs.-Suppl. |
| Beschreibung: | S. 45 - 88 graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011028209 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 961029s1995 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)231687007 | ||
| 035 | |a (DE-599)BVBBV011028209 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Trough, peak ratio and duration of action |b implications for hypertensive effect and organ protection |c ed.: Bernhard Poletto |
| 264 | 1 | |a New York |b Elsevier |c 1995 | |
| 300 | |a S. 45 - 88 |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a American journal of hypertension |v 8,10,2 | |
| 500 | |a Einzelaufnahme eines Zs.-Suppl. | ||
| 650 | 0 | 7 | |a Trandolapril |0 (DE-588)4359132-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sekundärkrankheit |0 (DE-588)4131705-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antihypertonikum |0 (DE-588)4002286-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Trandolapril |0 (DE-588)4359132-2 |D s |
| 689 | 0 | 1 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 1 | 1 | |a Sekundärkrankheit |0 (DE-588)4131705-1 |D s |
| 689 | 1 | 2 | |a Prävention |0 (DE-588)4076308-0 |D s |
| 689 | 1 | 3 | |a Antihypertonikum |0 (DE-588)4002286-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Poletto, Bernhard |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007384042 | ||
Datensatz im Suchindex
| _version_ | 1804125518140801024 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011028209 |
| ctrlnum | (OCoLC)231687007 (DE-599)BVBBV011028209 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01660nam a2200445 cb4500</leader><controlfield tag="001">BV011028209</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">961029s1995 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231687007</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011028209</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Trough, peak ratio and duration of action</subfield><subfield code="b">implications for hypertensive effect and organ protection</subfield><subfield code="c">ed.: Bernhard Poletto</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Elsevier</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 45 - 88</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">American journal of hypertension</subfield><subfield code="v">8,10,2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Suppl.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Trandolapril</subfield><subfield code="0">(DE-588)4359132-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sekundärkrankheit</subfield><subfield code="0">(DE-588)4131705-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antihypertonikum</subfield><subfield code="0">(DE-588)4002286-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Trandolapril</subfield><subfield code="0">(DE-588)4359132-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Sekundärkrankheit</subfield><subfield code="0">(DE-588)4131705-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Antihypertonikum</subfield><subfield code="0">(DE-588)4002286-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Poletto, Bernhard</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007384042</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV011028209 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:02:50Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007384042 |
| oclc_num | 231687007 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | S. 45 - 88 graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Elsevier |
| record_format | marc |
| series2 | American journal of hypertension |
| spelling | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection ed.: Bernhard Poletto New York Elsevier 1995 S. 45 - 88 graph. Darst. txt rdacontent n rdamedia nc rdacarrier American journal of hypertension 8,10,2 Einzelaufnahme eines Zs.-Suppl. Trandolapril (DE-588)4359132-2 gnd rswk-swf Sekundärkrankheit (DE-588)4131705-1 gnd rswk-swf Antihypertonikum (DE-588)4002286-9 gnd rswk-swf Hypertonie (DE-588)4026372-1 gnd rswk-swf Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Trandolapril (DE-588)4359132-2 s Wirkstofffreisetzung (DE-588)4190018-2 s DE-604 Hypertonie (DE-588)4026372-1 s Sekundärkrankheit (DE-588)4131705-1 s Prävention (DE-588)4076308-0 s Antihypertonikum (DE-588)4002286-9 s Poletto, Bernhard Sonstige oth |
| spellingShingle | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection Trandolapril (DE-588)4359132-2 gnd Sekundärkrankheit (DE-588)4131705-1 gnd Antihypertonikum (DE-588)4002286-9 gnd Hypertonie (DE-588)4026372-1 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd Prävention (DE-588)4076308-0 gnd |
| subject_GND | (DE-588)4359132-2 (DE-588)4131705-1 (DE-588)4002286-9 (DE-588)4026372-1 (DE-588)4190018-2 (DE-588)4076308-0 (DE-588)4143413-4 |
| title | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection |
| title_auth | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection |
| title_exact_search | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection |
| title_full | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection ed.: Bernhard Poletto |
| title_fullStr | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection ed.: Bernhard Poletto |
| title_full_unstemmed | Trough, peak ratio and duration of action implications for hypertensive effect and organ protection ed.: Bernhard Poletto |
| title_short | Trough, peak ratio and duration of action |
| title_sort | trough peak ratio and duration of action implications for hypertensive effect and organ protection |
| title_sub | implications for hypertensive effect and organ protection |
| topic | Trandolapril (DE-588)4359132-2 gnd Sekundärkrankheit (DE-588)4131705-1 gnd Antihypertonikum (DE-588)4002286-9 gnd Hypertonie (DE-588)4026372-1 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd Prävention (DE-588)4076308-0 gnd |
| topic_facet | Trandolapril Sekundärkrankheit Antihypertonikum Hypertonie Wirkstofffreisetzung Prävention Aufsatzsammlung |
| work_keys_str_mv | AT polettobernhard troughpeakratioanddurationofactionimplicationsforhypertensiveeffectandorganprotection |